Reports are emerging about the projected growth of various markets related to RNA analysis and therapeutics. The size and share of these markets, including mRNA therapeutics and RNA therapeutics, are expected to increase, with some outlets providing specific forecasts and valuations for the period up to 2034 or 2035. The growth of these markets appears to be linked to advancements in related fields, such as CRISPR technology and nucleic acid therapeutics.